Salivary Gland Neoplasms - 20 Studies Found
Recruiting |
: Study of I-125 Brachytherapy Versus Intensity-modulated Radiation Therapy to Treat Inoperable Salivary Gland Cancer : Salivary Gland Cancer : 2014-01-23 :
|
Recruiting |
: Androgen Deprivation Therapy in Advanced Salivary Gland Cancer : Salivary Gland Cancer : 2013-09-24 :
|
Recruiting |
: Activity of Sorafenib in Salivary Gland Cancer : Salivary Gland Cancer : 2012-04-06 : Drug: Sorafenib 400 mg twice daily, on a continuous basis (each morning and evening), in 4 week cycles |
Active, not recruiting |
: Eribulin Mesylate in Treating Patients With Recurrent or Metastatic Salivary Gland Cancer :
|
Completed |
: Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers :
: 2004-11-05 : |
Active, not recruiting |
: Trial of BIBF1120 (Nintedanib) in Patients With Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck : Recurrent or Metastatic Salivary Gland Cancer of the Head and Neck : 2015-09-22 : Drug: BIBF1120 Nintedanib will be given orally at a dose of 200mg twice daily (bid) until progression or |
Not yet recruiting |
: Nivolumab and Ipilimumab in Treating Patients With Metastatic Recurrent Major or Minor Salivary Gland Cancer :
|
Active, not recruiting |
: Phase II Study of Pazopanib in Patients With Progressive Recurrent and/or Metastatic Salivary Gland Carcinoma : Salivary Gland Carcinoma : 2015-03-13 : Drug: pazopanib treatment will be given until progression or unacceptable toxicity . |